 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
***FIRST PICK**** BYWD The staff of RTP proudly presents you with our first pick; this is an excellent opportunity to get in on the ground floor of a company with huge potential before it gets noticed by the rest of the investment community. We have completed our research and are sending it along to assist in your due diligence. The staff of RTP feels that it has identified a company whose sales and profits will explode in the months and years ahead. We expect its stock price to do the same. Below are a summary of the main reasons why we selected the company we did as our First Pick: 1) This Nasdaq BB company is presently profitable ($.01 EPS for the first quarter = approx $.04 EPS for the year without even accounting for growrth). This represents a Price/Earnings ratio of only 2. This company we feel should be trading at at least a P/E of 15 due to the pending developments and extremely strong revenue and profit growth. A P/E of 15 represents a stock price of $.60 2) This company has demonstrated massive growth rate. Last quarter showed growth of over 46% from the previous quarter. We are expecting this type of growth to continue as the company introduces new product lines, expands its international business, establishes itself in the US marketplace on a more widespread basis, and possibly mergers or acquires with other companies in the natural products industry 3) This company recently announced the signing of a Letter of Intent to commit to a Joint Venture in Chili. When finalized, a Chilean company will be formed that will be the marketing and Distribution center for two lines of nutritional products into two separate areas of the Chilean market. Revenue will be significantly increased because of this Joint Venture. We are looking to see a news release of this Joint Venture being finalized anytime now, and this news should skyrocket the stock price. 4) The company recently announced a new product line which should also significantly increase both revenues and profits. 5) The company recently broke through into the United States marketplace. Previously, they had done nearly all sales internationally but with the release of the new products, look for Baywood to make an impact in the American market in a very short period of time. This will also significantly increase revenues. 6) The stock is sitting at its all-time low levels. This assures us that we are getting in on the ground floor with a company that we expect to explode in the next 3-6 months. Now, it is with great pleasure that the staff of RTP present you with our first pick: (OTC:BB - BYWD) Baywood International. Below is the research we have compiled which should assist you in the due diligence process . ************************************************************************************ Company: BAYWOOD INTERNATIONAL, INC. Stock Symbol: BYWD (Nasdaq OTC: BB) Address: 14950 North 83rd Place, Scottsdale, Arizona 85260 Phone: (602) 951-3956 Fax: (602) 483-2168 Contact: Neil T. Reithinger (President & CEO) 52-week low: $0.05 52-week high: $0.39 Current BidxAsk: $.06x.07 Avg. Volume (past 30 days): 20,000 Outstanding Shares: 24.5 million (Francis Choi in China owns over 10 million himself or 42% of shares) FLOAT: 8.5 million EPS: $.01 for 1st quarter ending Mar. 31,1998. Multiplied by 4 quarters = approx. $.04 EPS for the year P/E Ratio: approx. 2 Revenue Growth: 46.5% per annum Fully-Reporting: YES (fiscal period is the calendar year) Most recent financials: Net sales for the QUARTER ended March 31, 1998 increased to $754,862 compared to net sales of $515,371 for the same period last year, an increase of $239,491 or 46.5%. Net income for the quarter was $116,981 or $.01 per share compared to a net loss of $(40,376) or less than $(.01) per share for the same period last year. This is just for the first quarter; we are anticipating revenues of over $5million for the current year and significantly higher for next year. Recent Developments: 1) Baywood International signed a letter of intent to form a joint venture to market its nutritional supplements into the South American market. As part of expanding the company's distribution into other countries in the international market, Baywood International Inc. has entered into a letter of intent to form a Chilean company that will be the marketing and distribution center for two lines of nutritional products into two separate areas of the Chilean market. The company, which will carry Baywood's name, is developing a sports nutrition line which will be sold through health clubs and gyms and a nutriceutical line which will be sold through physicians. Each line will be developed and marketed as a Baywood brand as part of establishing the continued brand penetration and recognition of the company's products into the international market. Chile, a country of 14 million people, has one of the fastest growing and sophisticated economies in South America. Baywood's products are well positioned to benefit from the growing awareness in health and related products in Chile. 2) Baywood International Completes New Line of Nutriceuticals: Baywood's new line of nutriceuticals designed for health food store distribution across the United States follows the Company's introduction of Beta-s(TM), formulated to maintain healthy cholesterol levels. This new line of products is formulated with what the company considers the most effective ingredients and dosages to target specific needs of consumers. The products include sinuS(TM) for soothing sinus support, anti-OX(TM) as a powerful antioxidant for molecular and cellular protection, energy+(TM) for support against fatigue, jointS(TM) for connective tissue and joint support, stop-snore(TM) for relief of snoring, eyeZ(TM) for support for healthy vision, memor-E(TM) for memory and brain support, cardio-V(TM) for healthy cardiovascular support, immune+(TM) for immune system support and moodZ(TM) for natural mood enhancement. All of these products are intended for domestic distribution through the company's existing distributors. Baywood's new sales office in Florida with the Company's new 1-888-350-0799 number will receive the incoming calls from consumer advertising for placement of orders through the distributors and control the outgoing sales support calls to the health food stores. Pending Developments: 1) Second Quarter financials will be released within 3 weeks. First quarter they made approx. $.01 EPS with growth of 46% over the previous quarter. Look for even stronger second quarter results due to several new products, increased sales internationally (recently they added Sharon Chou Korf as International Sales Manager to further develop and strengthen its position in the Pacific Rim Countries) as well as a breakthrough into the North American marketplace which should significanly increase sales and profits. 2) Baywood is in the process of researching some acquisitions or mergers with other companies in the natural products business. News of this significance would cause for the stock price to absolutely skyrocket. 3) Look for additional products to be released by the end of the year. We anticipate Baywood introducing even more products to their ever-increasing product line to aid sales both in the United States as well as Internationally Summary of Business: Baywood International, Inc. develops, markets and distributes nutritional supplements and skin care products. Since its inception, the Company has directed most of its sales efforts toward international markets and has established either distribution or registration of its products into the Pacific Rim Countries (China, Malaysia, Hong Kong, Taiwan and Indonesia) as well as Europe (Italy, Germany, Austria, England and Switzerland). Establishing distribution into health food stores, chain drug stores, grocery chains and network marketing companies internationally and in the United States is also part of the Company's marketing strategy. At this time, the Company is focused on strengthening its international distribution, building its distribution of branded products through health food stores in the United States and acquiring or merging with other companies in the natural products business. All of the Company's products are currently manufactured by third party manufacturers. Products: The Company's main dietary supplement products include bee pollen, bee propolis, royal jelly and a freeze dried aloe vera and mineral drink. The Company includes as separate products multiple sizes and potencies of certain products. At any point depending on customer demand or market opportunity, the Company may add to its dietary supplement line of products making the number of products and the mix in the types of products sensitive to change constantly toward the demands of what customers or the markets desire. The Company's most popular product is a freeze dried aloe vera and mineral drink under the brand name, Aloe-Minerals Plus(TM), which is part of the Company's Royal(TM) Line. This line is the primary name under which most of the Company's dietary supplements are sold internationally. Depending on the demands of a particular customer, the Company may also supply most products unlabeled, in bulk or under a private label. Although the Company considers the potential of unlabeled or privately labeled products to be substantial, emphasizing the Company's own branded products for presentation to the international and domestic market is important toward the Company's recognition in the natural products industry. The Company's dietary supplement products also include products that target specific nutritional needs, or what are referred to as nutriceuticals. These products are being marketed through the Company's natural healthcare line. The main product in this line is a cholesterol product designed and marketed to maintain healthy cholesterol. Under the Company's Royal(TM) Line marketed internationally, this product is called Count Down 200(TM). This product is also marketed under another brand name internationally called LDL Tab(TM). Domestically, this is the Company's first product called Beta-s(TM) and it is being marketed into health food stores across the United States. The Company intends to build upon the successful launch of this product into the United States through the introduction of other products for the natural healthcare line including those products which are formulated for certain needs such as joint support, allergy, cardiovascular support, memory and concentration, mood support, energy, eyes, immune system support, snore relief and a potent antioxidant. In addition to dietary supplements, the Company also has a line of skin care products. The main products in this line are marketed together as a facial system and include a cleanser, lift powder with activator, toner and a nurture cream. The products are aloe vera based and are primarily marketed under the Company's La Vraie(TM) brand line. Baywood's new line of nutriceuticals designed for health food store distribution across the United States follows the Company's introduction of Beta-s(TM), formulated to maintain healthy cholesterol levels. This new line of products is formulated with what the company considers the most effective ingredients and dosages to target specific needs of consumers. The products include sinuS(TM) for soothing sinus support, anti-OX(TM) as a powerful antioxidant for molecular and cellular protection, energy+(TM) for support against fatigue, jointS(TM) for connective tissue and joint support, stop-snore(TM) for relief of snoring, eyeZ(TM) for support for healthy vision, memor-E(TM) for memory and brain support, cardio-V(TM) for healthy cardiovascular support, immune+(TM) for immune system support and moodZ(TM) for natural mood enhancement. ************************************************************************************ The RTP newsletter is run by a group of individual investors. We are not financial advisors. The object of RTP, is to supply information, on companies which the RTP Staff feel are undervalued. RTP does not accept payments from companies, to post their information here. All target prices are strictly the opinion of the RTP Staff. We were NOT compensated in any form for the disbursement of this report; this was simply our own research and findings that we choose to share with our subscribers. RTP is not responsible for your investment actions. RTP never gives a direct invitation to buy or sell a stock. You should always do your own research, before investing in any company. You must also understand the risks involved, when investing into one of RTP's picks. Past performance should not be used, to predict future returns. Be aware that the RTP Staff may have positions in their picks. They may also sell their shares of that company, without any kind of notice. Always verify and do your own research before investing. | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |